IP Library › Granted Patent US 7,615,364
Granted Patent B2
US 7,615,364 · App. 11/660,093 · Granted Nov 10, 2009

Polypeptide having activity of unsaturating W3-fatty acid, polynucleotide coding for the polypeptide and use thereof

Assignee: Suntory Holdings Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,615,364
App. No.
11/660,093
Granted
Nov 10, 2009
Kind
B2
Abstract

The present invention provides a polypeptide having a wide substrate specificity and having a ω3 fatty acid desaturation activity, which makes efficiently unsaturated bond at ω3 position, and a polynucleotide coding for the same. By expressing the polypeptide in the organism, mass production of n-3 series PUFAs is enabled. Specifically, the polypeptide having a ω3 fatty acid desaturation activity and consisting of the amino acid sequence represented by SEQ ID NO: 1, a polynucleotide coding for a polypeptide having a ω3 fatty acid desaturation activity that consists of the base sequence represented by SEQ ID NO: 2 or SEQ ID NO: 3, and the like is useful for production of n-3 series fatty acids.

Claims (15)

1. An isolated polynucleotide coding for a polypeptide having an ω3 fatty acid desaturation activity, which is:

(a) a polypeptide consisting of the amino acid sequence represented by SEQ ID NO: 1, or

(b) a polypeptide consisting of an amino acid sequence, wherein one to 10 amino acids are substituted, deleted, inserted, or added in the amino acid sequence represented by SEQ ID NO: 1.

2. An isolated polynucleotide coding for a polypeptide having a ω3 fatty acid desaturation activity, which is any of (c), (d), (e) or (f) described below:

(c) a polynucleotide consisting of the base sequence represented by SEQ ID NO: 2 or SEQ ID NO: 3;

(d) a polynucleotide consisting of the base sequence from 14 to 1366 of the base sequence represented by SEQ ID NO: 2;

(e) a polynucleotide having at least 90% sequence identity to the base sequence represented by SEQ ID NO: 2 or SEQ ID NO: 3

(f) a polynucleotide having at least 90% sequence identity to the base sequence from 14 to 1366 of the base sequence represented by SEQ ID NO: 2.

3. A vector comprising the polynucleotide of claim 1 .

4. A non-human transformant, wherein the polynucleotide of claim 1 is introduced.

5. The transformant of claim 4 , which is fungus, animal, plant or progeny thereof, or a cell or tissue therefrom.

6. The transformant of claim 5 , wherein the plant is soybean, rapeseed, sesame, olive, linseed, maize, sunflower or safflower.

7. The transformant of claim 4 , wherein composition of the fatty acid is modified.

8. A method for producing a polypeptide, comprising using the vector of claim 3 .

9. A method for producing a polypeptide, comprising using the transformant of claim 4 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2009
From: SUNTORY LIMITED
To: SUNTORY HOLDINGS LIMITED
Reel/Frame 022865/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2007
From: SHIMIZU, SAKAYU; SAKURADANI, EIJI
To: SUNTORY LIMITED
Reel/Frame 018948/0108 →
Priority Claims (1)
JP 2004-241671 · Aug 20, 2004 · national
Continuity (1)
Related Publication 20080032335A1 · Feb 7, 2008